Anser Innovation appoints Amanda Brinkman to Board of Directors, expanding list of influential leaders supporting the company’s move to Ōmcare commercialization

NEWS RELEASE

(FOR IMMEDIATE RELEASE)

Anser Innovation appoints Amanda Brinkman to Board of Directors, expanding list of influential leaders supporting the company’s move to Ōmcare commercialization

Brinkman’s career includes leadership positions at the world’s top creative agencies and corporations, as well as a track record of business development successes

BURNSVILLE, MN (JANUARY 16, 2020) – Anser Innovation and Ōmcare announced today that Amanda Brinkman has been appointed to its Board of Directors. Brinkman is currently Chief Brand Officer at Deluxe Corporation and creator, producer, and host of the hit series on HULU “Small Business Revolution – Main Street.”

Ōmcare, a wholly-owned subsidiary of Anser Innovation, is a Minnesota-based digital health company that aims to extend the reach of caregivers and improve medication adherence and outcomes through its Ōmcare Home Health Hub, which gives caregivers of all types – from physicians and pharmacists to home care providers or family members – the ability to see and speak to elderly or disabled dependents and confirm compliance with medication treatment plans from anywhere. The easy-to-use Ōmcare system is designed to facilitate remote monitoring and interaction via visual confirmation of a patient’s actions, which supports telehealth and virtual care services, and gives family members greater peace of mind.

“Amanda has amassed an extremely impressive marketing, public relations, and business development track record that will allow her to provide critical guidance to Anser Innovation as we move toward the commercialization of the Ōmcare Home Health Hub in 2020,” said Lisa Lavin, Founder and CEO of Anser Innovation and its family of companies. “In addition to her critical marketing acumen, boundless energy, and creative mindset, Amanda’s personal credo of ‘doing well by doing good’ is a perfect fit with our core values and brand aspirations.”

Brinkman’s accolades and achievements include a feature in Minnesota Business’ “The Next Generation of Minnesota Business Titans;” being named to the magazine’s “Power 50,” which recognizes the most influential leaders in the business community; and a cover feature in Twin Cities Business Magazine. She has held executive-level positions at Allianz and UnitedHealth Group. In addition to leading internal creative agencies and business strategy at these top corporations, Brinkman has demonstrated her creative expertise through her work at cutting-edge creative firms, Fallon and McCann Minneapolis.

Brinkman is also a board member for the Ordway Performing Arts Center, the Children’s Theatre Company, the Association of National Advertisers (ANA) and the Women’s Business Development Center Chicago. She has also served on the boards for Children’s Cancer Research Fund, Make-A-Wish, and The Salvation Army. She passionately volunteers for an array of causes, including the Special Olympics, Feed My Starving Children, People Serving People, the Down Syndrome Association of Minnesota, the Jeremiah Program, and more. Brinkman is also a member of the Minnesota Women’s Economic Roundtable.

“I believe in brands that move beyond brand purpose and take real brand action, making a difference in the lives of their customers,” said Brinkman. “Ōmcare provides just that by extending the reach of caregivers and empowering independence. This is a life-changing technology and I am thrilled to help raise awareness for this revolutionary approach.”

Ōmcare earned its third patent from the United States Patent and Trademark Office (U.S. Patent No. 10,347,377) for the company’s web-enabled, audiovisual, medication-dispensing telemedicine system for the home in 2019. The device made its official debut at the Leading Age Annual Conference and Expo late last year, where it earned nods from industry media as an “emerging technology in the caregiving space.”  Ōmcare was also recently named among the “20 Hottest Flyover Tech Companies” by The New York Observer, based on insights from a panel of healthcare and business experts at the 38th Annual JP Morgan Healthcare Conference.  To learn more, visit www.omcare.com.

 

###

For more information:

Barbara Tabor, APR  /  (651) 450-1342  /  barbara@taborpr.com

About Ōmcare

Ōmcare is a digital health company aspiring to extend the reach of the caregiver, increase medication adherence, and to improve treatment outcomes by harnessing the power of remote care. We aim to achieve this through our proprietary interactive technologies - promising right pill, right time, right person. By partnering with pharmacies, payers, providers, and family caregivers, our vision is to help people live healthier, more vibrant, independent lives.


Five new health and caregiving technologies November 2019

LeadingAge in San Diego and more.  Entrepreneurs clearly see the opportunity for providing tech-enabled services to help care for older adults.  Large events like Leading Age, Argentum, and sub-events within CES and HIMSS all point to the business potential that draws startups as well as new offerings from existing players – in what may become an increasingly crowded market. Here five recent announcements, two from the Startup Garage at Leading Age in San Diego -- adding three others from recent press releases.  All information is drawn from the websites of the companies themselves.

Ōmcare (LeadingAge) "Ōmcare is far more than a pill sorting system with self-reported validation. With three issued patents and more pending, Ōmcare’s in-home remote dispensing and integrated care monitoring will drive a new way to measure adherence and set a new standard for care coordination that is simple, safe and easy to use. Ōmcare links remote dispensing with video confirmation such that every dispensing event is directly observed and confirmed. Caregivers know immediately if a dose is missed or incorrectly administered.  Other smart pill dispensers and mobile compliance apps depend on self-reporting rather than direct observation. Ōmcare’s approach will change how the industry measures medication adherence." Learn more at Ōmcare.

Read the full article from Aging In Place Technology Watch here.


Healthcare Innovation Startups: Most Successful Companies of the Last 10 Years

Today, the healthcare startup scene is booming. With 2018 projected to be the biggest year for investing for the healthcare industry, the future appears promising as more and more groundbreaking companies emerge into the field with bold strategies for solving problems.

However, the healthcare startup landscape wouldn’t be so prosperous without the prominent startups that emerged from the earlier days and succeeded. As the list of startups continues to grow, here are seven of the most successful healthcare startups of the last 10 years.

AbbVie

Headquartered in North Chicago, this biopharmaceutical company was founded in 2013 by Richard Gonzales. Abbvie, which originated as a spin-off of Abbott Laboratories combines advanced science, expertise, and passion to solve serious health issues, which has had a huge impact on people’s lives all around the world. AbbVie currently has ~29,000 employees in over 175 countries and made $28.2 billion in revenue. 

Privia Health

A physician practice management and population health technology company, Privia Health works towards keeping people healthy, preventing disease, and improving care coordination both in and outside of the doctor’s office. The private company incorporates key partnerships with employers, health systems and technology, team based-care, and a unique wellness programs to help them on their mission.

Adaptive Biotechnologies

A pioneer and leader in combining high-throughput sequencing and bioinformatics to profile T-cell and B-cell receptors, Adaptive Biotechnologies definitely belongs on this list due to their influence and work within the healthcare sphere. Their immunosequencing platform drives groundbreaking research in cancer and other immune-mediated diseases, which they hope to use to improve patient care and clinical diagnostics.

WeDoctor  

Dubbed the “Amazon of healthcare,” WeDoctor is the one of the world’s leading medical health technology platforms. Based in China and founded in 2010 by Jerry Liao Jieyuan, WeDoctor works towards addressing the problem of China’s underfunded and overstretched hospitals. Currently WeDoctor has more than 150 million registered users in China for their online appointment booking, prescription, and diagnostic services. The privately held company is valued at $5.5 billion.

Moderna Therapeutics

Moderna Therapeutics works towards creating MRNA medicines for a wide range of diseases and conditions. Based in Cambridge, MA, the company uses mRNA medicines which allows them to take advantage of normal biological processes to create a desired therapeutic effect. Because of this, they can treat a broad spectrum of diseases, some of which do not have current therapies. Moderna Therapeutics was valued as high as $5B in 2017 by some analysts.

Reata Pharmaceuticals

Reata Pharmaceuticals is biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. Reata’s mission is to identify, develop, and commercialize novel therapeutics to address serious and life-threatening diseases with few or no approved therapies by targeting molecular pathways that regulate cellular metabolism and inflammation. Reata’s lead product candidates, bardoxolone methyl and omaveloxolone, are Nrf2 activators, which are a transcription factor for restoring mitochondrial function, reducing oxidative stress, and resolving inflammation.

Vezeeta

Vezeeta.com is the leading digital healthcare booking platform and practice management software in MENA that works towards helping the shift towards automated physician, clinic, and hospital bookings to make healthcare more accessible in the region. With over 200,000 verified reviews, patients are able to search, compare, and book the best doctors for them through Vezeeta.

Ōmcare

Our mission isn’t to capitalize on the booming healthcare market, but to push the industry’s success even further with our technology and forward-thinking philosophy. With the Ōmcare Telemed System, we are looking to tackle the problem of medication non-adherence. Of all prescriptions that are filled, 50% are taken incorrectly by the patient. Furthermore, there are 125,000 deaths each year and over $300 billion lost in healthcare costs annually.

At Ōmcare, we are driven to extend the reach of caregivers while enabling face-to-face care from anywhere. Through our technology and innovation, we are actively working towards decreasing the cost of care and empowering patients of all types. We can do what no one else has done before: deliver real medication adherence. We partner with pharmacies, payers, providers, and family caregivers to help people live a healthy, indiependent, and vibrant life no matter their situation.

To stay up to date on the latest news from us, as well as the release of our Telemed System, subscribe to our email.


Startups That Are Disrupting Healthcare in 2019 (5 Companies to Watch)

It’s no secret that the healthcare industry has become a formidable presence in the startup arena, garnering hundreds of millions of dollars in investing this year. In fact, according to a Forbes article, all signs point to 2018 being a record breaking year for healthcare VC investing.

Because of this hyperactive market, there has been an increase in the amount of healthcare startups looking to capitalize on this interest from investors. This means that it’s getting harder to separate the contenders from the pretenders when it comes to these new companies. To help identify the cream of the crop, here is the definitive list of the top five healthcare startups to keep an eye on in 2019.

Virta

Virta is doing great work in helping those with diabetes, and they’ll continue to do more great things in 2019. Virta Health has delivered the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without the use medications or surgery. In there first year of treatments, 60% of their patients achieved diabetes reversal, 94% of insulin users reduced or eliminated their usage, and 83% of patients remained active in the trial. This is one healthcare startup we’ll for sure keep our eye on in the coming year.

Ōmcare

Ōmcare is an innovative healthy technology company and startup that address medication non-adherence through the use of their Ōmcare Telemed System. The product, which features video chat interface, 3-way calling capabilities, medication dispensing and consumption assistance, and adherence confirmation will be available mid-2019. The Ōmcare Telemed System offers caregivers of all types – physicians, pharmacists. and family – the ability to see, speak to, and confirm appropriate medication from anywhere. Ōmcare also addresses the growing twin problems of social isolation and the shortage of paid and unpaid caregivers in the senior market. The real costs of medication non-adherence and loneliness are more than just dollars and cents, and Ōmcare understands that.

Helix

Helix is a startup that is working towards “democratizing DNA” with their genetic testing marketplace. What makes Helix an exciting company to pay close attention to is their business model. They differentiate themselves from other genomics testing companies like 23andMe by requesting a single one time donation that allows their customers access to their marketplace of testing options. Everyone has a right to know about their ancestral history, and Helix is making it accessible to all.

PEAR Therapeutics

PEAR is actually the first company to receive an FDA clearance for a prescription digital therapeutic that works towards improving clinical outcomes in a disease. PEAR uses software applications that have been clinically-validated with pharmaceutical and treatment paradigms to provide results for their patients, which includes those with diabetes, obesity, Alzheimer’s, asthma, ADHD, depression, anxiety, and more.

Sensely  

Sensely is a digital health company that uses an avatar-based, empathy-driven application that helps clinicians and their patients keep track and manage their health. The platform, highlighted by the virtual assistant “Molly,” includes data integration, images and videos, text to speech capabilities, and speech recognition. Sensely provides access to high quality medicine by utilizing artificial intelligence, a trend we’ll likely see continue in the healthcare startup sector.

 

Why Investing in Healthcare is Smart

More-so than any other industry, healthcare is an essential part of our everyday lives. Not just certain people, but everyone is affected by healthcare technology. Startups in this industry are working diligently to change the world by weaving new technology, drug and genetic advances, analytics and AI into solutions that impact our health, quality of life, and wallet.

While there have been many groundbreaking achievements in healthcare over the years, there is still so much opportunity to produce better, faster, and more efficient diagnoses, treatments, and management. Not only are there large returns to be had for investing in these companies, but you’ll lend a hand in the next big healthcare breakthrough.


Anser Innovation Seeks Funds to Develop Medication Management Device

The company behind PetChatz, a device which connects pet owners to their fur babies while they’re away from home, has a new healthcare product in the pipeline. Anser Innovation is nearly halfway toward a fundraising target to finish developing its latest creation, Ōmcare, according to a recent filing with the Securities and Exchange Commission (SEC).

Burnsville-based Anser wants to raise $1.7 million more toward a goal of $3 million, the filing indicates. The new product, Ōmcare, is a home eHealth hub and audiovisual medication management system meant to ensure people take the right pills at the right time.

Read the full article from Twin Cities Business here.


IoT Startup Anser Innovation Attracts More Investment For New Product Line

The latest infusion builds off a previously closed $500k, now at $1.3m of $3m, in pursuit of a medication management system targeting the elder care population as well as opiate use disorder.

Ōmcare, as the new product is branded, is a “Home eHealth Hub and Audiovisual Medication Management system that promises visual confirmation of ‘the right pill at the right time’ for true medication adherence.”

Read the full article from TECHdotMN here.